title: Rational development of cell-penetrating high affinity SH3 domain binding peptides that selectively disrupt the signal transduction of Crk family adapters. Amgen Peptide Technology Group.
authors.affiliation: Laboratory of Molecular Oncolology, MSZ, University of Würzburg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Kardinal
authors.forename: G
authors.initials: G
authors.lastname: Posern
authors.forename: J
authors.initials: J
authors.lastname: Zheng
authors.forename: B S
authors.initials: BS
authors.lastname: Knudsen
authors.forename: I
authors.initials: I
authors.lastname: Moarefi
authors.forename: S M
authors.initials: SM
authors.lastname: Feller
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D002461:Cell Line, Transformed; D006801:Humans; D009687:Nuclear Proteins / Q000378:metabolism*; D015398:Signal Transduction; D014407:Tumor Cells, Cultured; D018909:src Homology Domains
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C082869:CRKL protein; D009687:Nuclear Proteins